NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









In-Med Prognostics

In-Med Prognostics

Private
PuneHealthcare & Life Scienceshttps://inmed.ai/

Last Round

Seed

Dec 12, 2022

Total Funding Raised

$2.2M

Company Overview

In-Med Prognostics is a healthtech company that provides an AI-driven platform for analyzing medical images to aid in the assessment and early detection of neurological disorders.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Healthcare Analytics, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

medical AImedical image analysisradiology AIbrain volumetryneurology diagnosticsclinical decision supportAI diagnosticsFDA 510(k) clearanceMRI analysisneurodegenerative diseaseprecision medicineradiology workflowethnicity-specific dataclinical trial software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

In-Med Prognostics Comparables

Compare In-Med Prognostics with similar companies based on industry and business-model similarity.

In-Med Prognostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

In-Med Prognostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 12, 2022
AcceleratorApr 15, 2021
GrantJan 9, 2019

Key People

Founding team and executive leadership

Latha Poonamallee

CEO And Co-Founder, Founder

Founding Team

Girish Srinivasan

Technology Advisor, CTO

Executive Team

Jignesh Agrawal

Consulting Chief Financial Officer

Executive Team

In-Med Prognostics Investors

Notable investors and investment history

In-Med Prognostics investors
InvestorRounds
Biotechnology Industry Research Assistance CouncilGrant
RICHAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 3, 2026

    Monthly visitors grew 105% MoM.

  • Jul 9, 2025

    Monthly visitors grew 48% MoM, from 322 to 475.

In-Med Prognostics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

In-Med Prognostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about In-Med Prognostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersPune
Employee Range17
Year Founded2018
Last FundingDec 12, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.